ALTHEOME
LIVE

Serial Number

79451635

Owner

Altheome Limited

Filing Date

Jan 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ALTHEOME Trademark

Serial Number: 79451635

ALTHEOME is a trademark filed by Altheome Limited on January 6, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Altheome Limited

Connect House,

Entity Type: 99

Trademark Details

Filing Date

January 6, 2026

Registration Date

Not Registered

Goods & Services

Biotechnological research services; scientific research services; laboratory research services; laboratory testing services; design and product development services; scientific analysis services; biological research services; medical research services; research and development services; clinical trials; DNA sequencing for medical research and technology research purposes; biotechnological research services, scientific research services, laboratory research services, laboratory testing services, design and product development services, scientific analysis services, biological research services, medical research services, research and development services, clinical trials, and DNA sequencing for medical research and technology research purposes, all the aforesaid services relating to proteomics, proteomics profiling services, quantitative and qualitative protein analysis services, biomarker discovery, biomarker development, biomarker analysis, biomarker assays, discovery and development of biomarker assays, running samples for biomarkers across proteomics and genomics, genomic sequencing, the analysis of protein biomarkers, microbiome analysis, multigenomics, structural and functional analysis of genomes, disease diagnosis, treatment monitoring and disease risk assessment; biotechnological research services, scientific research services, laboratory research services, laboratory testing services, design and product development services, scientific analysis services, biological research services, medical research services, research and development services, clinical trials, and DNA sequencing for medical research and technology research purposes, all the aforesaid services relating to testing for viruses, bacteria, parasites, yeast and antimicrobial resistance genes in areas including respiratory, blood culture identification, gastrointestinal, meningitis, encephalitis, pneumonia and joint infection; biotechnological research services, scientific research services, laboratory research services, laboratory testing services, design and product development services, scientific analysis services, biological research services, medical research services, research and development services, clinical trials, and DNA sequencing for medical research and technology research purposes, all the aforesaid services relating to testing across respiratory infection, GI infection, STIs, vaginitis, meningitis, healthcare associated infection, COVID, tuberculosis, human papilloma infection, single nucleotide polymorphism, vector-borne disease, streptococcal infection, monkeypox, dermatophyte, urinary tract infection; design and development of diagnostic assays, devices, and platforms; research in the field of bioinformatics; research in the field of biostatistics; computerised data storage and database design services relating to bioinformatics and biostatistics; data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases; computer modelling and computer simulation services; cloud computing services; design and development artificial intelligence and machine learning models; biological services, computer science services, and data analytics services, namely research in the field of bioinformatics, research in the field of biostatistics, data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases, computer modelling and computer simulation services, cloud computing services, design and development artificial intelligence and machine learning models, all the aforementioned services relating to proteomics, proteomics profiling services, quantitative and qualitative protein analysis services, biomarker discovery, biomarker development, biomarker analysis, biomarker assays, discovery and development of biomarker assays, running samples for biomarkers across proteomics and genomics, genomic sequencing, the analysis of protein biomarkers, microbiome analysis, multigenomics, structural and functional analysis of genomes, disease diagnosis, treatment monitoring and disease risk assessment; biological services, computer science services, and data analytics services, namely research in the field of bioinformatic, research in the field of biostatistics, data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases, computer modelling and computer simulation services, cloud computing services, design and development artificial intelligence and machine learning models, all the aforementioned services relating to testing for viruses, bacteria, parasites, yeast and antimicrobial resistance genes in areas including respiratory, blood culture identification, gastrointestinal, meningitis, encephalitis, pneumonia and joint infection; biological services, computer science services, and data analytics services, namely research in the field of bioinformatics, research in the field of biostatistics, data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases, computer modelling and computer simulation services, cloud computing services, design and development artificial intelligence and machine learning models, all the aforesaid services relating to testing across respiratory infection, GI infection, STIs, vaginitis, meningitis, healthcare associated infection, COVID, tuberculosis, human papilloma infection, single nucleotide polymorphism, vector-borne disease, streptococcal infection, monkeypox, dermatophyte, urinary tract infection; information, advisory and consultancy services relating to the aforesaid.

Pathological testing for diagnostic and treatment purposes; medical testing and analysis services relating to the diagnosis and treatment of disease; laboratory analysis services relating to the diagnosis and treatment of persons; pathological testing for diagnostic and treatment purposes, medical testing and analysis services relating to the diagnosis and treatment of disease, and laboratory analysis services relating to the diagnosis and treatment of persons, all relating to proteomics, proteomics profiling services, proteomics profiling services, quantitative and qualitative protein analysis services, biomarker discovery, biomarker development, biomarker analysis, biomarker assays, discovery and development of biomarker assays, running samples for biomarkers across proteomics and genomics, genomic sequencing, the analysis of protein biomarkers, microbiome analysis, multigenomics, structural and functional analysis of genomes, disease diagnosis, treatment monitoring and disease risk assessment; pathological testing for diagnostic and treatment purposes, medical testing and analysis services relating to the diagnosis and treatment of disease, and laboratory analysis services relating to the diagnosis and treatment of persons, all relating to testing for viruses, bacteria, parasites, yeast and antimicrobial resistance genes in areas including respiratory, blood culture identification, gastrointestinal, meningitis, encephalitis, pneumonia and joint infection; pathological testing for diagnostic and treatment purposes, medical testing and analysis services relating, all relating to testing across respiratory infection, GI infection, STIs, vaginitis, meningitis, healthcare associated infection, COVID, tuberculosis, human papilloma infection, single nucleotide polymorphism, vector-borne disease, streptococcal infection, monkeypox, dermatophyte, urinary tract infection; medical services; medical testing services; medical diagnostic services; medical analysis services; medical screening services; medical services, medical testing services, medical diagnostic services, medical analysis services, medical screening services, all relating to proteomics, proteomics profiling services, proteomics profiling services, quantitative and qualitative protein analysis services, biomarker discovery, biomarker development, biomarker analysis, biomarker assays, discovery and development of biomarker assays, running samples for biomarkers across proteomics and genomics, genomic sequencing, the analysis of protein biomarkers, microbiome analysis, multigenomics, structural and functional analysis of genomes, disease diagnosis, treatment monitoring and disease risk assessment; medical services, medical testing services, medical diagnostic services, medical analysis services, medical screening services, all relating to testing for viruses, bacteria, parasites, yeast and antimicrobial resistance genes in areas including respiratory, blood culture identification, gastrointestinal, meningitis, encephalitis, pneumonia and joint infection; medical services, medical testing services, medical diagnostic services, medical analysis services, medical screening services, all relating to testing across respiratory infection, GI infection, STIs, vaginitis, meningitis, healthcare associated infection, COVID, tuberculosis, human papilloma infection, single nucleotide polymorphism, vector-borne disease, streptococcal infection, monkeypox, dermatophyte, urinary tract infection; information, advisory and consultancy services relating to the aforesaid.

Filing History

ASSIGNED TO EXAMINER
Jun 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 12, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 11, 2026 REPR